ID   697-R
AC   CVCL_D3Z6
SY   697R
RX   PubMed=21538216;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:66484; Silvestrol.
CC   Sequence variation: Gene fusion; HGNC; 8632; PBX1 + HGNC; 11633; TCF3; Name(s)=TCF3-PBX1; E2A-PBX1 (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0079 ! 697
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   PubMed=21538216; DOI=10.1208/s12248-011-9276-7;
RA   Gupta S.V., Sass E.J., Davis M.E., Edwards R.B., Lozanski G.,
RA   Heerema N.A., Lehman A., Zhang X.-L., Jarjoura D., Byrd J.C., Pan L.,
RA   Chan K.K., Kinghorn A.D., Phelps M.A., Grever M.R., Lucas D.M.;
RT   "Resistance to the translation initiation inhibitor silvestrol is
RT   mediated by ABCB1/P-glycoprotein overexpression in acute
RT   lymphoblastic leukemia cells.";
RL   AAPS J. 13:357-364(2011).
//